Zura Bio Ltd
ZURA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001855644
No open-market purchases or sales by Zura Bio Ltd insiders were filed in the last 90 days; 95 institutions reported holding it in 13F filings for Q2 2026, worth $428.9M in total; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding Zura Bio Ltd changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 44 | 45 | +1 |
| Shares | 15.2M | 14.9M | −281.3K (−1.9%) |
| Value | $70.7M | $37.6M | −$33.1M (−46.8%) |
New holders (5)
Institutions that held Zura Bio Ltd at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Affinity Asset Advisors, LLC | 450,009 | $1.16M | 0.19% |
| Jane Street Group, LLC | 53,117 | $136.5K | 0.00% |
| Calamos Advisors LLC | 200,000 | $54.0K | 0.00% |
| UBS Group AG | 17,232 | $44.3K | 0.00% |
| Capital Advisors, Ltd. LLC | 33 | $0 | 0.00% |
Sold out (4)
Institutions that held Zura Bio Ltd at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Two Sigma Investments, LP | 32,486 | $151.7K |
| Goldman Sachs Group Inc | 19,458 | $90.9K |
| Susquehanna International Group, LLP | 12,037 | $56.2K |
| Amundi | 9,929 | $40.3K |